|
| 36068918 | Inducing mismatch repair deficiency sensitizes immune-cold neuroblastoma to anti-CTLA4 and generates broad anti-tumor immune memory. | Mol Ther | 2023 |
| 35008676 | TdIF1-LSD1 Axis Regulates Epithelial-Mesenchymal Transition and Metastasis via Histone Demethylation of E-Cadherin Promoter in Lung Cancer. | Int J Mol Sci | 2021 |
| 33584650 | Reduced CD5 on CD8<sup>+</sup> T Cells in Tumors but Not Lymphoid Organs Is Associated With Increased Activation and Effector Function. | Front Immunol | 2021 |
| 32178827 | DIY: Visualizing the immune landscape of tumors using transcriptome and methylome data. | Methods Enzymol | 2020 |
| 32081948 | Hepcidin-mediated Iron Regulation in P19 Cells is Detectable by Magnetic Resonance Imaging. | Sci Rep | 2020 |
| 32076794 | miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy. | Cancer Immunol Immunother | 2020 |
| 31943150 | CD5 blockade enhances ex vivo CD8<sup>+</sup> TÂ cell activation and tumour cell cytotoxicity. | Eur J Immunol | 2020 |
| 31594465 | miR-149-3p reverses CD8<sup>+</sup> T-cell exhaustion by reducing inhibitory receptors and promoting cytokine secretion in breast cancer cells. | Open Biol | 2019 |
| 29061656 | Synergistic Antiproliferative Activity of the RAD51 Inhibitor IBR2 with Inhibitors of Receptor Tyrosine Kinases and Microtubule Protein. | J Pharmacol Exp Ther | 2018 |
| 30345081 | TdIF1: a putative oncogene in NSCLC tumor progression. | Signal Transduct Target Ther | 2018 |
| 30288365 | Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy. | Oncoimmunology | 2018 |
| 29364966 | Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines. | PLoS One | 2018 |
| 27856600 | TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding. | Clin Cancer Res | 2017 |
| 29062467 | Correction: COTI-2, a novel small molecule that is active against multiple human cancer cell lines <i>in vitro</i> and <i>in vivo</i>. | Oncotarget | 2017 |
| 28789683 | Voluntary running exercise protects against sepsis-induced early inflammatory and pro-coagulant responses in aged mice. | Crit Care | 2017 |
| 26959114 | Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2. | Oncotarget | 2016 |
| 26429639 | Synergistic cytotoxicity against human tumor cell lines by oncolytic adenovirus dl1520 (ONYX-015) and melphalan. | Tumori | 2016 |
| 26472449 | Non-Covalently Functionalized of Single-Walled Carbon Nanotubes by DSPE-PEG-PEI for SiRNA Delivery. | Methods Mol Biol | 2016 |
| 27150056 | COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo. | Oncotarget | 2016 |
| 27290740 | From Solo in the Silo to Strategic Training Programs. | CBE Life Sci Educ | 2016 |
| 25741641 | Evaluating the effectiveness of cancer drug sensitization in vitro and in vivo. | J Vis Exp | 2015 |
| 26579709 | IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells. | PLoS One | 2015 |
| 26087398 | siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine. | Oncotarget | 2015 |
| 23942307 | Vaccinia virus outperforms a panel of other poxviruses as a potent oncolytic agent for the control of head and neck squamous cell carcinoma cell lines. | Intervirology | 2014 |
| 25216445 | Single-walled carbon nanotubes noncovalently functionalized with lipid modified polyethylenimine for siRNA delivery in vitro and in vivo. | Bioconjug Chem | 2014 |
| 24974076 | BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis. | Mol Oncol | 2014 |
| 24784564 | Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin. | Oncotarget | 2014 |
| 24884532 | Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy. | J Transl Med | 2014 |
| 24509175 | Targeted siRNA silencing of indoleamine 2, 3-dioxygenase in antigen-presenting cells using mannose-conjugated liposomes: a novel strategy for treatment of melanoma. | J Immunother | 2014 |
| 24424208 | Non-covalently functionalized single-walled carbon nanotube for topical siRNA delivery into melanoma. | Biomaterials | 2014 |
| 23836502 | Imaging tumor growth non-invasively using expression of MagA or modified ferritin subunits to augment intracellular contrast for repetitive MRI. | Mol Imaging Biol | 2014 |
| 22870862 | Silencing IDO in dendritic cells: a novel approach to enhance cancer immunotherapy in a murine breast cancer model. | Int J Cancer | 2013 |
| 23880315 | Metallothionein-I- and -II-deficient mice display increased susceptibility to cadmium-induced fetal growth restriction. | Am J Physiol Endocrinol Metab | 2013 |
| 23904762 | The epidemic of human papillomavirus and oropharyngeal cancer in a Canadian population. | Curr Oncol | 2013 |
| 23663293 | Does HPV type affect outcome in oropharyngeal cancer? | J Otolaryngol Head Neck Surg | 2013 |
| 23653877 | A case report and genetic characterization of a massive acinic cell carcinoma of the parotid with delayed distant metastases. | Case Rep Oncol Med | 2013 |
| 23787421 | High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancer. | JAMA Otolaryngol Head Neck Surg | 2013 |
| 23481354 | Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined "Complementary Lethality". | Mol Ther Nucleic Acids | 2013 |
| 22066590 | Imaging of homeostatic, neoplastic, and injured tissues by HA-based probes. | Biomacromolecules | 2012 |
| 23304554 | A Pilot Study Comparing HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas by Whole Exome Sequencing. | ISRN Oncol | 2012 |
| 22993321 | The Effects of N-acetylcysteine on ifosfamide efficacy in a mouse xenograft model. | Anticancer Res | 2012 |
| 22911296 | Frequent mutations in TP53 and CDKN2A found by next-generation sequencing of head and neck cancer cell lines. | Arch Otolaryngol Head Neck Surg | 2012 |
| 22493344 | Reduction of tumorigenicity by placental extracts. | Anticancer Res | 2012 |
| 22569013 | Ki-67 expression predicts radiotherapy failure in early glottic cancer. | J Otolaryngol Head Neck Surg | 2012 |
| 22076949 | Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system. | Head Neck | 2012 |
| 21375761 | Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? | J Transl Med | 2011 |
| 21673071 | Combining small interfering RNAs targeting thymidylate synthase and thymidine kinase 1 or 2 sensitizes human tumor cells to 5-fluorodeoxyuridine and pemetrexed. | J Pharmacol Exp Ther | 2011 |
| 20482488 | Antisense treatment in human prostate cancer and melanoma. | Curr Cancer Drug Targets | 2010 |
| 18986763 | Enhancement of cytotoxicity of natural product drugs against multidrug resistant variant cell lines of human head and neck squamous cell carcinoma and breast carcinoma by tesmilifene. | Cancer Lett | 2009 |
| 19723470 | Magnetic resonance imaging of cells overexpressing MagA, an endogenous contrast agent for live cell imaging. | Mol Imaging | 2009 |